• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN

Dive Deeper with Tymora

cropped-Complete-Logo-web-header.png

In collaboration with

Tymora-New logo - 2021

Tymora's Superior Proteomics Services

Discover the full capabilities of your samples with Tymora Analytical's Proteomics Services. Using their proprietary EVtrap technology, Tymora provides a comprehensive analysis of proteins and their post-translational modifications (PTMs) from various biological samples. Identify critical biomarkers and gain a deeper understanding of intricate biological processes.

Whether you're working with plasma, urine, saliva, or tissue samples, Tymora's Proteomics Services provide a reliable platform for your research requirements. Here's what Tymora offers:

Tymora_Icons-01

Plasma

Probe the comprehensive protein and PTM profile of plasma-derived EVs.

Identify >1,000 unique proteins from just 10 µL plasma, or 600-1,000 unique phosphoproteins from just 0.5 mL plasma.

Tymora_Icons-02

Urine

Harness the power of truly non-invasive urine samples to uncover unique biomarkers.

10 mL of urine can detect 3,200 phosphopeptides and 1,200 phosphoproteins.

Tymora_Icons-03

Saliva

Explore the potential of saliva as a rich source of disease-specific EVs.

Identify >1,000 unique proteins from just 20 µL saliva, or 500-1,000 unique phosphoproteins from just 1 mL saliva.

Tymora_Icons-04

Tissue

Unearth the complex interplay of proteins and their modifications within specific tissues.

Analyze low-abundant proteins, phosphoproteins, glycoproteins, and others from frozen tissue samples.

Tymora_Icons-05-05

Cell Lysate

Get an in-depth view of the proteomic landscape of your cell cultures.

Analyze low-abundant proteins, phosphoproteins, glycoproteins, and others from frozen cells or cell lysate samples.

Tymora_Icons-06

Other Samples

Tymora accommodates a wide range of sample types, catering to your diverse research needs.

Custom services are available for most sample types (e.g., plant, fungi, bacteria, IP, in-gel digests, etc.).

EVtrap

Test EVtrap NOW!

Let's Go!

Mention IMev2023 for a special discounted rate!

Discover Powerful, Non-Invasive Biomarkers

Exosomes are extracellular vesicles generated by all cells and they carry nucleic acids, proteins, lipids, and metabolites. They are mediators of near and long-distance intercellular communication in health and disease and affect various aspects of cell biology. (Kalluri and LeBleu. Science 2020. doi: 10.1126/science.aau6977)
Exosomes are extracellular vesicles generated by all cells and they carry nucleic acids, proteins, lipids, and metabolites. They are mediators of near and long-distance intercellular communication in health and disease and affect various aspects of cell biology. (Kalluri and LeBleu. Science 2020. doi: 10.1126/science.aau6977)

Unlock new frontiers in non-invasive biomarker discovery with Tymora Analytical. Extracellular vesicles (EVs), including exosomes, offer a unique window into the health status of their originating cells by their distinct protein profiles. When isolated from urine, they present a wealth of clinically relevant data. Tymora Analytical stands at the forefront of this pioneering approach, using their proprietary EVtrap technology and Proteomics/PTMs analysis. By extracting and profiling proteins and their post-translational modifications (PTMs) from EVs in urine, they provide researchers with comprehensive insights into disease processes, helping to advance personalized medicine.

JUMPSTART YOUR PROJECT

Get your results in two to three weeks! Here's how it works:

  • Sample Shipment
  • Sample Analysis
  • Data Processing
  • Results Delivery
Analyze My Samples

Comparison of Extracellular Vesicle (EV) Purification and Isolation Methods

wdt_ID Principle/Method Benefits Disadvantages Processing Time Reported Purity Reported Yield References
1 EVtrap High yield, purity and
reproducibility.
Compatible with
proteomics analysis,
automatable, easy
to use with standard equipment.
Higher cost,
elution buffer
needs to be dried
or neutralized.
< 1 hour High (>99%) High (>95%)

1-3

2 Ultracentrifugation Current benchmark Time consuming,
low yield,
cumbersome process,
may damage exosomes
> 4 hours Medium Medium

4

3 Density gradient centrifugation High purity, avoiding
exosomal damage
Labor-intensive,
preliminary preparation
and cumbersome
operation
>16 h High Low

5

4 Ultrafiltration Easy, without special
equipment and
reagents
Clogging on filtering
membrane, loss of
exosomes of small
particle diameter
Generally <4 h High Medium

6

5 Size exclusion chromatography Simple, economical,
maintain the
biological function
and structure
Special columns and
packing are required,
lipoprotein
contamination
0.3 h for qEV High High 7
6 Immunoaffinity High specificity for
exosome subtypes
isolation
Expensive, depending
on specificity of the
antibody
4–20 h High Medium 8
7 Polymer co-precipitation Simple operation,
suitable for large-volume
samples
Potential contaminants
(co-purifying protein
aggregates or residuary
polymers)
≈0.3–12 h Low High

8

(Table modified from Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, Du L. (2022). Review on strategies and technologies for exosome isolation and purification. Front. Bioeng. Biotechnol. doi: 10.3389/fbioe.2021.811971.)

REFERENCES
REFERENCES
  1. Iliuk AB. (2022). Purification and Phosphoproteomic Analysis of Plasma-Derived Extracellular Vesicles. Methods Mol Biol. doi: 10.1007/978-1-0716-2341-1_11.
  2. Iliuk A, Wu X, Li L, Sun J, Hadisurya M, Boris RS, Tao WA. (2020). Plasma-Derived Extracellular Vesicle Phosphoproteomics through Chemical Affinity Purification. J Proteome Res. doi: 10.1021/acs.jproteome.0c00151.
  3. Wu X, Li L, Iliuk A, Tao WA. (2018). Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles. J Proteome Res. doi: 10.1021/acs.jproteome.8b00459.
  4. Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q, et al. (2020). Progress in Microfluidics-Based Exosome Separation and Detection Technologies for Diagnostic Applications. Small. doi:10.1002/smll.201903916
  5. Kamerkar S, Lebleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. (2017). Exosomes Facilitate Therapeutic Targeting of Oncogenic KRAS in Pancreatic Cancer. Nature. doi:10.1038/nature22341
  6. Ding L, Yang X, Gao Z, Effah CY, Zhang X,Wu Y, et al. (2021). A Holistic Review of the State-of-the-Art Microfluidics for Exosome Separation: An Overview of the Current Status, Existing Obstacles, and Future Outlook. Small. doi:10.1002/smll.202007174
  7. Mohammadi M, Zargartalebi H, Salahandish R, Aburashed R, Wey Yong K, and Sanati-Nezhad, A. (2021). Emerging Technologies and Commercial Products in Exosome-Based Cancer Diagnosis and Prognosis. Biosens. Bioelectron. doi:10.1016/j.bios.2021.113176
  8. Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S., et al. (2017). Methodological Guidelines to Study Extracellular Vesicles. Circ. Res. doi:10.1161/CIRCRESAHA.117.309417
EVtrap

Test EVtrap NOW!

Let's Go!

Mention IMev2023 for a special discounted rate!

Sidebar

"*" indicates required fields

Name*
Email me a copy
Consent

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

Return to top

Tymora Inquiry Form

"*" indicates required fields

Step 1 of 2

0%
What type of sample(s) are you looking to have analyzed?*
Please provide details about your requirements for sample analysis, and feel free to ask any questions you may have. Our team is here to guide you through the process.
Name*
Location*
Consent*
Caleb-Schlachter-for-web

Caleb R. Schlachter, Ph.D.

Principal Scientist
Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
Gray Amick for web

Gray D. Amick, Ph.D.

Director of Operations
Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
Amanda M Headshot

Amanda C. McGee

Research Scientist
Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
Andrew_Headshot

L. Andrew Lee, Ph.D.

Co-Founder and Chief Scientific Officer
L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

Get started with 2N1 below

"*" indicates required fields

Name*
Would you be interested in joining the 2N1 beta program?*
Which product are you interested in? (select all that apply)*
What are your current purification workflows? (select all that apply)*
Please select your automation platform(s) (select all that apply)*
How soon are you planning on evaluating 2N1?*
Consent*

DOWNLOAD OUR POSTERS

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*

Dynamic title for modals

Are you sure?

Please confirm deletion. There is no undo!